Diagnostic Accuracy of a Combination of Preoperative 68-Ga Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer

Abstract

<b><i>Introduction:</i></b> Prostate cancer (PCa) is a common and leading course of cancer-related death in men. Although there are studies on multiparametric magnetic resonance imaging (MpMRI) with good diagnostic results in detecting clinically significant PCa, new methods have been investigated due to the low positive predictive values. In this context, prostate-specific membrane antigen positron emission tomography (PSMA PET) emerges as an alternative imaging method to MpMRI. This study aimed to compare ⁶⁸Ga PSMA I&amp;T-PET/CT and MpMRI in determining tumor location. <b><i>Methods:</i></b> Preoperative MpMRI and ⁶⁸Ga PSMA I&amp;T-PET/CT scans and pathology specimens of patients who underwent radical prostatectomy for PCa at our clinic between 2018 and 2021 were retrospectively evaluated. PSMA I&amp;T-PET/CT, MpMRI, combined imaging were compared for tumor localization according to histopathological data. <b><i>Results:</i></b> In terms of tumor localization, MpMRI demonstrated overall accuracy rates of 75.9% (<i>p</i> kappa [κ] 0.0001* [0.525]). ⁶⁸Ga PSMA I&amp;T-PET/CT showed 71.5% (<i>p</i> κ 0.0001* [0.438]). For the combined imaging approach, the overall accuracy rate was calculated as 79.2% (<i>p</i> κ 0.0001* [0.576]). Additionally, high diagnostic accuracy was achieved for the combined imaging approach, particularly in the intermediate ISUP group. Moreover, SUVmax was calculated as 6.37. <b><i>Conclusion:</i></b> The combined use of ⁶⁸Ga PSMA I&amp;T-PET/CT and MpMRI has high diagnostic rates. However, the high cost is a significant disadvantage that limits their routine combined use.